Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trial
D. Tan, J. Raboud, R. Kaul, B. Grinsztejn, P. Cahn, S. Walmsley
Trials